Try Alerts Free   |   Login
Health Care › Dental Equipment And Supplies

Biolase Technology (BIOL) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with BIOL stock chart to see long term trends.

BIOL stock compared to

BIOL Income Statement

Revenue, Net:8520000
Revenue Per Share:0.14
Cost of Goods & Services Sold:6915000
Gross Profit:1605000
Selling, General & Admin Expense:3767000
Research & Development Expense:1051000
Total Operating Expenses:7143000
Operating Income:-4200000
Income Taxes:32000
Net Income:-6138000
Earnings Per Share, Basic:-0.04
Shares Outstanding, Basic Avg:61136000

BIOL Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:-28000
Change in Accounts Receiveable:-269000
Net Cash from Operations:-1348000
Net Cash from Financing Activities:-53000
Property, Plant & Equipment Purchases:18000
Net Cash from Investing Activities:-18000
Net Change in Cash & Equivalents:-1283000

BIOL Balance Sheet

Cash and Cash Equivalents:17876000
Accounts Receivable, Net:3059000
Total Current Assets:35110000
Property, Plant & Equipment, Net:782000
Total Assets:41025000
Accounts Payable:2651000
Current Portion of Long-Term Debt:null
Total Short-Term Liabilities:11223000
Long Term Debt, Non-Current Portion:16186000
Total Liabilities:30997000

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Oracle Investment Management Inc
1,739,100 sh
Vanguard Group Inc
773,926 sh
-236,939 sh
Sabby Management, LLC
333,458 sh
333,458 sh
Blackrock Inc.
270,063 sh
3 sh
Virtu Financial LLC
269,185 sh
255,783 sh
Northern Trust Corp
39,155 sh
-16,955 sh
Proequities, Inc.
16,240 sh
Bank Of America Corp /De/
154 sh
-43 sh
Royal Bank Of Canada
1 sh
-156 sh
Renaissance Technologies LLC
0 sh
-544,695 sh
Morgan Stanley
0 sh
-6 sh

Data imported from Biolase Technology Inc SEC filings. Check original filings before making any investment decision.